ProjectAtlas-Studie – Efficacy, Safety, and Pharmacokinetic Profile of ANB020 in Adults with Moderate-to-Severe Atopic…
Basic data
Acronym:
Atlas-Studie
Title:
Efficacy, Safety, and Pharmacokinetic Profile of ANB020 in Adults with Moderate-to-Severe Atopic Dermatitis
Duration:
01/09/2018 to 31/12/2019
Abstract / short description:
Protocol Title: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study
Investigating the Efficacy, Safety, and Pharmacokinetic Profile of ANB020 Administered to Adult Subjects
with Moderate-to-Severe Atopic Dermatitis
Investigating the Efficacy, Safety, and Pharmacokinetic Profile of ANB020 Administered to Adult Subjects
with Moderate-to-Severe Atopic Dermatitis
Keywords:
atopic dermatitis
Atopische Dermatitis
Involved staff
Managers
Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Local organizational units
Department of Dermatology
Hospitals and clinical institutes
Faculty of Medicine
Faculty of Medicine
Funders
San Diego, Kalifornien, United States